Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariela Cabrera

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Multiple Sclerosis and Related Disorders|August 27, 2023
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in ArgentinaRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 30, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in ArgentinaEdgar Carnero Contentti, Pablo A López, Agustín Pappolla, et al.
Multiple Sclerosis and Related Disorders|September 3, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMJuan I Rojas, Geraldine G Luetic, Carlos Vrech, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?Geraldine G Luetic, María Laura Menichini, Carlos Vrech, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Multiple Sclerosis and Related Disorders|August 27, 2023
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in ArgentinaRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 30, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in ArgentinaEdgar Carnero Contentti, Pablo A López, Agustín Pappolla, et al.
Multiple Sclerosis and Related Disorders|September 3, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMJuan I Rojas, Geraldine G Luetic, Carlos Vrech, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?Geraldine G Luetic, María Laura Menichini, Carlos Vrech, et al.
Pageof 2